Tg Therapeutics reported $-85637000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Ardelyx ARDX:US $ 43.59M 88.77M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Arrowhead Research ARWR:US $ -63.37M 33.45M
Biogen BIIB:US $ 814.2M 255M
Curis CRIS:US $ -11.05M 0.21M
Infinity Pharmaceuticals INFI:US $ -10.71M 0.56M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Novartis NOVN:VX SF 4544M 120M
Novavax NVAX:US $ -316.39M 32.38M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Spectrum Pharmaceuticals SPPI:US $ -33.07M 16.85M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Verastem VSTM:US $ -22.79M 5.88M